Acquiring Company
Curium US Holdings
Acquired Company
Lantheus Holdings
DelawareBedfordManufacturingBiotechnologyHealth CareBiotechnologyHealth CareTherapeuticsDescription
On August 3, 2026, Lantheus Holdings, Inc. entered into a merger agreement with Curium US Holdings LLC, in which Lantheus will merge into Curium's subsidiary. The merger is subject to regulatory approval and conditions outlined in the agreement. The companies expect to complete the merger in the first half of 2027. Both parties are cooperating with the FTC regarding the review process.
Who to call at Curium US Holdings, and when
When Curium US Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Curium US Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Curium US Holdings, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Curium US Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Lantheus Holdings?
Lantheus Holdings was acquired by Curium US Holdings, based in Delaware. The deal was reported on October 22, 2026. Curium US Holdings LLC is a prominent provider of nuclear medicine services and radio pharmaceuticals. Curium US Holdings is privately held and operates in Manufacturing.
When did Curium US Holdings acquire Lantheus Holdings?
Curium US Holdings's acquisition of Lantheus Holdings was reported on October 22, 2026. On August 3, 2026, Lantheus Holdings, Inc. entered into a merger agreement with Curium US Holdings LLC, in which Lantheus will merge into Curium's subsidiary. The merger is subject to regulatory approval and conditions outlined in the agreement. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Lantheus Holdings do?
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. It is publicly traded (LNTH), operating in Biotechnology, and is based in Bedford.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.